Heart Disease News and Research

Latest Heart Disease News and Research

Novel patient engagement tool improved outcomes for heart failure patients

A novel patient engagement tool led one in five patients with heart failure to a more effective treatment regimen of generic medications, according to late- breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Two-thirds of older Americans would not seek treatment for depression, new poll shows

A new nationwide poll, the GeneSight Mental Health Monitor, shows that nearly two-thirds (61%) of Americans age 65 or older who have concerns about having depression will not seek treatment.

17 Nov 2020

New program can remotely improve cardiovascular health for broad population of patients

Despite being known risk factors for poor cardiovascular outcomes, blood pressure and low-density lipoprotein (LDL) cholesterol remain undertreated among a large proportion of patients.

17 Nov 2020

Overweight and obesity in younger people associated with higher risk of severe COVID-19

Being younger doesn't protect against the dangers of COVID-19 if you are overweight, according to a new study from UT Southwestern.

17 Nov 2020

Study investigates possible link between sleep apnea and autoimmune diseases

New research by University of Georgia scientists sheds light on why people with obstructive sleep apnea may have associated autoimmune disorders. The results could lead to better approaches to treatment and possibly new drug therapies.

17 Nov 2020

Study identifies new factor that offers potential strategy for treating obesity

Obesity is a serious global health problem and a risk factor for diseases such as type II diabetes, heart disease and fatty liver disease.

17 Nov 2020

An acebuchin-oil-enriched diet helps to reduce arterial blood pressure

An acebuchin-oil-enriched diet helps to reduce arterial blood pressure, as shown by a study carried out by the Cardiovascular Physiopathology research group at the Physiology Department of the University of Seville.

17 Nov 2020

Investigational drug helped improve heart health in patients with chronic conditions

The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events in patients with chronic kidney disease and Type 2 diabetes, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Combination of ticagrelor and aspirin reduces subsequent stroke risk in patients with heart plaque

Patients with plaque build-up in their arteries, who suffered a transient ischemic attack (TIA) or a minor ischemic stroke, also called a warning stroke, and were treated with the newer blood thinner ticagrelor plus aspirin were 27% less likely to have another stroke within 30 days, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Hydrogen therapy may help severely ill COVID-19 patients

Researchers from the Department of Critical Care Medicine, Sichuan Provincial People's Hospital, Chengdu in China, have explored the possibility of using hydrogen therapy on severely ill COVID-19 patients. The team published their study's findings, titled "Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients," in the latest issue of the journal Frontiers in Pharmacology.

17 Nov 2020

Novel drug reduces the risk of cardiovascular events for patients with Type 2 diabetes, kidney disease

A novel diabetes medication significantly reduces the risk of hospitalization for heart failure, heart attack and stroke, in patients with Type 2 diabetes and chronic kidney disease, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Lower dairy intake may be beneficial for people with metabolic syndrome

Results from a new trial published by a team led by researchers at Fred Hutchinson Cancer Research Center suggests lower dairy intake may be beneficial for people with metabolic syndrome.

17 Nov 2020

Cynical hostility poses the greatest risk for cardiovascular disease

Cynical hostility is a potential pathway to cardiovascular disease by preventing a healthy response to stress over time, according to a study led by Baylor University.

17 Nov 2020

Scientists reveal new evidence of electrical pathway in the heart

These days having both a land line and a mobile phone seems like overkill. But Virginia Tech researchers have shown that the heart relies on at least two key communication channels to keep abnormal heart rhythms in check.

17 Nov 2020

ESC event examines the hottest topics in digital medicine

Digital health is transforming the way patients and healthcare professionals interact. Join us for ESC Digital Health Week from 30 November to 3 December and examine the hottest topics in digital medicine.

17 Nov 2020

Short bursts of intense exercise could help people get fit in time for summer

Short bursts of intense exercise – known as HIIT – could help you get back into shape by summer and stay that way, a UNSW Sydney exercise physiology researcher says.

17 Nov 2020

Study shows favorable impact of medication on cardiac structure and function

For the first time, medication has impacted heart muscle thickness and function for patients with the most common inherited heart condition, rather than simply addressing their symptoms.

17 Nov 2020

Vitamin D and omega-3 fatty acids do not prevent atrial fibrillation, shows study

New research presented today at the American Heart Association Scientific Sessions suggests neither vitamin D nor the omega-3 fatty acids found in fish oil prevent the development of atrial fibrillation, a potentially serious heart rhythm disturbance.

17 Nov 2020

Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes

Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.

16 Nov 2020

Combination of polypill and aspirin can reduce cardiovascular events by up to 40%

Heart attacks, strokes and other cardiovascular incidents can be cut by 20 to 40 per cent through use of a polypill which combines three blood pressure medications and a lipid lowering medication taken alone or with aspirin.

16 Nov 2020

Heart Disease News and Research

Latest Heart Disease News and Research

Novel patient engagement tool improved outcomes for heart failure patients

Two-thirds of older Americans would not seek treatment for depression, new poll shows

New program can remotely improve cardiovascular health for broad population of patients

Overweight and obesity in younger people associated with higher risk of severe COVID-19

Study investigates possible link between sleep apnea and autoimmune diseases

Study identifies new factor that offers potential strategy for treating obesity

An acebuchin-oil-enriched diet helps to reduce arterial blood pressure

Investigational drug helped improve heart health in patients with chronic conditions

Combination of ticagrelor and aspirin reduces subsequent stroke risk in patients with heart plaque

Hydrogen therapy may help severely ill COVID-19 patients

Novel drug reduces the risk of cardiovascular events for patients with Type 2 diabetes, kidney disease

Lower dairy intake may be beneficial for people with metabolic syndrome

Cynical hostility poses the greatest risk for cardiovascular disease

Scientists reveal new evidence of electrical pathway in the heart

ESC event examines the hottest topics in digital medicine

Short bursts of intense exercise could help people get fit in time for summer

Study shows favorable impact of medication on cardiac structure and function

Vitamin D and omega-3 fatty acids do not prevent atrial fibrillation, shows study

Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes

Combination of polypill and aspirin can reduce cardiovascular events by up to 40%

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in